Skip to content
Home/Companies/Biotech/Evergreen Theragnostics
Evergreen Theragnostics

Evergreen Theragnostics

Biotech·United States·Exited 2025·Held 1yr
Entry
2024
Hold
1yr
Exit
2025

Who owns Evergreen Theragnostics?

Evergreen Theragnostics was owned by LIFTT through LIFTT (2019 vintage) from 2024 to 2025, exited via Trade Sale.

Buyer identity and MOIC available on Pro.

Hand-verified · updated 2026-07-31

LIFTT
Investor
LIFTT
LIFTT · 2019 · VC

Key facts

HQUnited States
SectorBiotech
StatusAcquired
Websitewww.evergreentgn.com
Exit Type
Trade Sale
Buyer
MOIC
Exit Year
2025

More from LIFTT

Other portfolio companies in the same fund.

Rainbow Crops
Active
AgTechBelgium· 2026
Vitrealab
Active
Deep TechAustria· 2026
Agate Sensors
Active
Deep TechFinland· 2025
Qsensato
Active
Deep TechItaly· 2025
RAAAM Memory Technologies
RAAAM Memory Technologies
Active
Deep TechIsrael· 2025
Composite Research
Composite Research
Active
IndustrialsItaly· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track Evergreen Theragnostics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Evergreen Theragnostics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue